SOLICITATION NOTICE
66 -- Storm 860-w/o screen
- Notice Date
- 5/3/2004
- Notice Type
- Solicitation Notice
- NAICS
- 334516
— Analytical Laboratory Instrument Manufacturing
- Contracting Office
- Department of Health and Human Services, National Institutes of Health, National Cancer Institute, Research Contracts Br., 6120 Executive Blvd. EPS Suite 600, Rockville, MD, 20852
- ZIP Code
- 20852
- Solicitation Number
- RFQ-NCI-40061-NQ
- Response Due
- 5/17/2004
- Archive Date
- 6/1/2004
- Point of Contact
- Cynthia Brown, Purchasing Agent, Phone (301) 496-8608, Fax (301) 402-4513, - Renita Smith, Contract Specialist, Phone 301-496-8612, Fax 301-480-0241,
- E-Mail Address
-
cb106x@nih.gov, rs442i@nih.gov
- Description
- The National Cancer Institute (NCI), Center for Cancer Research (CCR), Radiation Oncology Branch (ROB) intends on entering into a sole source contract with Amersham Biosciences, 800 Centennial Avenue, Piscataway, NJ 08854 for a Storm 860 ImageQuant without screen. This procurement is being processed based on FAR Part 13 Simplified Acquisition Procedures. The North American Industry Classification Code is 334516 and the Business size standard is 500 employees. The ROB research is involved with studies emphasizing the need to understand the cellular and molecular events following radiation exposure due to treatment, which requires the identification of proto-oncogenes. The Storm 860 is the only system known to the NCI researchers capable of scanning storage phosphor screens, fluorescent DNA and protein gels, chemifluorescent DNA/RNA, protein blots and chemilumeniscent Western blots on one system. The Storm 860 provides two high power excitation sources, one at 633 nm for screening storage phosphor screens and red-excited fluorescent samples and another at 532nm for scanning green-excited fluorescent and chemifluoriscent samples. The required system will also be used for the identification of proto-oncogenes, genes that are the first response after the treatment with radiation, aid in defining the proteins that these genes encode. The Storm 860 will allow the ROB the capability of cloning and identifictaion of human and other mammalian genes and to elucidate the function of the proteins that these genes encode; as well as allow agarose gel separation of multiple sample, high fidelity PCR techniques, southern, northern and western blotting, multicolor fluorescence detection and quantification of various molecules. Amersham Biosciences is the only source known to the Government that can provide the above features. However, if any interested party believes it can meet the above requirements, it may submit a statement of capabilities. The capability statement and any other furnished information must be in writing and must contain material in sufficient detail to allow NCI to determine if the party can fully meet the requirements herein. Capability statements must be received in the contracting office no later than 1:30 P.M. EDT (local Washington, D.C. time) on May 17, 2004. If you have any questions please contact Cynthia Brown, Purchasing Agent on 301-402-4509. A determination by the Government not to compete this proposed requirement based on responses to this notice is solely within the discretion of the Government. Information received will be considered solely for the purpose of determining whether to conduct a competitive procurement. No collect calls will be accepted. Please reference solicitation number RFQ-NCI-40061-NQ on all correspondence.
- Record
- SN00578682-W 20040505/040503211744 (fbodaily.com)
- Source
-
FedBizOpps.gov Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |